SHALBY.NS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 18:00):

Stats
今日成交量	111 454
平均成交量	258 734
市值	28.53B
EPS	INR0 ( 2024-02-12 )
下一个收益日期	( INR0 ) 2024-05-12
Last Dividend	INR1.200 ( 2023-08-08 )
Next Dividend	INR0 ( N/A )
P/E	34.84
ATR14	INR0.436 (0.17%)

音量相关性

長: 0.11 (neutral)

短: 0.18 (neutral)

Signal:(38.821) Neutral

Shalby Limited 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Shalby Limited 相关性 - 货币/商品

-0.54
( weak negative )

-0.51
( weak negative )

-0.19
( neutral )

-0.54
( weak negative )

-0.43
( neutral )

0.46
( neutral )

Shalby Limited 财务报表

Annual	2022
营收:	INR8.05B
毛利润:	INR3.70B (45.94 %)
EPS:	INR6.30

FY	2022
营收:	INR8.05B
毛利润:	INR3.70B (45.94 %)
EPS:	INR6.30

FY	2022
营收:	INR6.99B
毛利润:	INR3.05B (43.58 %)
EPS:	INR6.46

FY	2021
营收:	INR4.31B
毛利润:	INR1.81B (42.07 %)
EPS:	INR4.71

Financial Reports:

No articles found.

Shalby Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR1.000 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR1.200 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Shalby Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.43 - low (14.10%) | Divividend Growth Potential Score: 4.32 - Stable (13.68%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.500	2019-08-16
Last Dividend	INR1.200	2023-08-08
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	INR4.20	--
Avg. Dividend % Per Year	0.51%	--
Score	1.91	--
Div. Sustainability Score	3.43
Div.Growth Potential Score	4.32
Div. Directional Score	3.87	--

Next Divdend (Est)
(2024-07-01)

INR1.377 Estimate 3.09 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.91

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2019	INR0.500	0.34%
2020	INR0.500	0.54%
2021	INR1.000	0.92%
2022	INR1.000	0.70%
2023	INR1.200	0.79%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RAYMOND.NS	Dividend Junior	2023-06-23	Sporadic	29	0.15%
KOTARISUG.NS	Dividend Junior	2023-08-03	Sporadic	11	0.58%
EVERESTIND.NS	Dividend Junior	2023-08-14	Annually	22	0.75%
AMBIKCO.NS	Dividend Junior	2023-09-22	Annually	17	1.61%
SYRMA.NS	No Dividend Player	2023-09-01	Insufficient data to determine frequency	2	0.18%
NEWGEN.NS	Dividend Knight	2023-06-20	Annually	7	2.26%
IFGLEXPOR.NS	Dividend Junior	2023-08-17	Annually	21	1.57%
CHAMBLFERT.NS	Dividend Junior	2023-08-21	Annually	23	1.58%
SAGCEM.NS	Dividend Junior	2023-06-20	Annually	18	0.28%
LTIM.NS	Dividend Knight	2023-07-10	Semi-Annually	9	0.87%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0916	1.500	8.17	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0860	1.500	-0.155	-0.233	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	10.77	1.000	7.12	7.12	[3 - 30]
operatingCashFlowPerShareTTM	6.92	2.00	7.69	10.00	[0 - 30]
freeCashFlowPerShareTTM	6.92	2.00	6.54	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.464	1.000	5.60	5.60	[0.2 - 0.8]
operatingProfitMarginTTM	0.150	1.000	9.00	9.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.43

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	35.01	1.000	6.56	0	[1 - 100]
returnOnEquityTTM	0.0860	2.50	-0.0997	-0.233	[0.1 - 1.5]
freeCashFlowPerShareTTM	6.92	2.00	7.69	10.00	[0 - 30]
dividendYielPercentageTTM	0.451	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	6.92	2.00	7.69	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.274	1.500	4.84	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0834	1.000	-0.415	0	[0.1 - 0.5]
Total Score				4.32

Shalby Limited

Shalby Limited operates multi-specialty hospitals primarily in India. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implant ology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver disease and transplant, and hip and knee joint replacement services. It also provides infectious disease, infertility and IVF, intensive and critical care, maxillofacial surgery, nephrology, neuro surgery, neurology, obesity surgery, obstetrics and gynecology, oncology, oncosurgery, ophthalmology and glaucoma, orthopedic and trauma, pediatric orthopedic, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest, radiology and imaging, rheumatology, trauma, organ donation, and urosurgery services. The company operates 11 hospitals comprising aggregate capacity of 2,012 beds. In addition, it offers outpatient services through 50 outpatient clinics, as well as provides educational programs and fellowships for paramedical students and other healthcare professionals; and homecare health services, such as attendants, doctors, nursing, physiotherapy, pathology, pharmacy, and medical equipment, as well as conducts clinical research trials. It also operates in Kenya, Tanzania, Rwanda, Uganda, the United Arab Emirates, Bangladesh, Cambodia, Jakarta, Oman, Uzbekistan, Nepal, and internationally. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is headquartered in Ahmedabad, India.